Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Intensive (Pre)Clinical Characterization of Patients undergOing Atrial fibrillATion ablatlON: a Multicenter Clinical Care and Research Platform

NCT05381805 is registered in ClinicalTrials.gov with Maastricht University Medical Center as lead sponsor.

NCT NCT05381805
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05381805 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Intensive (Pre)Clinical Characterization of Patients undergOing Atrial fibrillATion ablatlON: a Multicenter Clinical Care and Research Platform
Lead sponsor
Maastricht University Medical Center
Phase
Observational
Overall status
Not yet recruiting
Start date
August 1, 2022
Completion date
August 1, 2028
Enrollment
1,500 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

atrial fibrillation